Hjem › Kreft (alle typer) › Michigan › Ann Arbor
Kliniske studier for Kreft (alle typer) i Ann Arbor, MI
25 studier for Kreft (alle typer) søker deltakere på steder i og rundt Ann Arbor (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study of ASP3082 in Adults With Advanced Solid Tumors
RekruttererFase 1
- Trinity Health Ann Arbor Hospital, Ypsilanti · 7 mi unna
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
RekruttererObservasjonsstudie
- University of Michigan, Ann Arbor
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
RekruttererFase 1
- University of Michigan, Ann Arbor
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
RekruttererFase 3
- University of Michigan Health System, Ann Arbor
Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia
RekruttererFase 3
- Quetzal Site 22, Ann Arbor
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruttererFase 2
- Trinity Health Ann Arbor Hospital, Ann Arbor
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
RekruttererFase 2/3
- University Of Michigan Comprehensive Cancer Center, Ann Arbor
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruttererFase 2
- University of Michigan, Ann Arbor
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
RekruttererFase 1/2
- University of Michigan Health System - Ann Arbor /ID# 271536, Ann Arbor
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- University of Michigan, Ann Arbor
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruttererFase 3
- University of Michigan, Ann Arbor
Prostate Active Surveillance Study
RekruttererObservasjonsstudie
- University of Michigan, Ann Arbor
Lurbinectedin in FET-Fused Tumors
RekruttererFase 1/2
- University of Michigan, Ann Arbor
Project: Every Child for Younger Patients With Cancer
RekruttererObservasjonsstudie
- C S Mott Children's Hospital, Ann Arbor
Abatacept in Immune Checkpoint Inhibitor Myocarditis
RekruttererFase 3
- University of Michigan, Ann Arbor
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
RekruttererFase 2
- C.S. Mott Children's Hospital, Ann Arbor
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruttererFase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi unna
- og 6 flere
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
RekruttererFase 2
- University of Michigan Health System - Ann Arbor /ID# 273511, Ann Arbor
Childhood Cancer Survivor Study
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- University of Michigan/Mott Children's Hospital, Ann Arbor
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
RekruttererFase 1
- University of Michigan Comprehensive Cancer Center Michigan Medicine /ID# 252010, Ann Arbor
Suprachoroidal Administration in Subjects With Metastases to the Choroid
RekruttererFase 2
- Kellogg Eye Center, Ann Arbor
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
Rekrutterer
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Ann Arbor
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekrutterer
- University of Michigan Medical Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi unna
Kreft (alle typer)-studier i andre byer
- Houston, TX121 studier
- New York City, NY109 studier
- Boston, MA85 studier
- Los Angeles, CA74 studier
- Nashville, TN65 studier
- Philadelphia, PA59 studier
- Washington, DC58 studier
- Durham, NC58 studier
- Chicago, IL51 studier
- Atlanta, GA49 studier
- Seattle, WA49 studier
- Arlington, VA48 studier
Andre studier i Ann Arbor
- Brystkreft27 studier
- Prostatakreft27 studier
- Ikke-småcellet lungekreft26 studier
- Lungekreft23 studier
- Kolorektal kreft23 studier
- Hjertesvikt22 studier
- Akut myelogen leukemi17 studier
- Kardiovaskulær sykdom16 studier
- Pankreaskreft14 studier
- Melanom12 studier
- Slag12 studier
- Plateepitelcancer i hode og hals12 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.